The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Uveal melanoma: Towards a molecular understanding
Open accessAbstract
Uveal melanoma is an aggressive malignancy that originates from melanocytes in the eye. Even if the primary tumor has been successfully treated with radiation or surgery, up to half of all UM patients will eventually develop metastatic disease. Despite the common origin from neural crest-derived cells, uveal and cutaneous melanoma have few overlapping genetic signatures and uveal melanoma has been shown to have a lower mutational burden. As a consequence, many therapies that have proven effective in cutaneous melanoma -such as immunotherapy- have little or no success in uveal melanoma. Several independent studies have recently identified the underlying genetic aberrancies in uveal melanoma, which allow improved tumor classification and prognostication of metastatic disease. In most cases, activating mutations in the Gα11/Q pathway drive uveal melanoma oncogenesis, whereas mutations in the BAP1, SF3B1 or EIF1AX genes predict progression towards metastasis. Intriguingly, the composition of chromosomal anomalies of chromosome 3, 6 and 8, shown to correlate with an adverse outcome, are distinctive in the BAP1mut, SF3B1mut and EIF1AXmut uveal melanoma subtypes. Expression profiling and epigenetic studies underline this subdivision in high-, intermediate-, or low-metastatic risk subgroups and suggest a different approach in the future towards prevention and/or treatment based on the specific mutation present in the tumor of the patients. In this review we discuss the current knowledge of the underlying genetic events that lead to uveal melanoma, their implication for the disease course and prognosis, as well as the therapeutic possibilities that arise from targeting these different aberrant pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
COSMIC: the Catalogue Of Somatic Mutations In Cancer
Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N., Boutselakis, H., Cole, C. G., Creatore, C., Dawson, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1015 · Cited by 4,867
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Emerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A., Zhang, H., McLellan, M., Yau, C., Kandoth, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.033 · Cited by 1,858
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512
Mutations in GNA11 in Uveal Melanoma
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,476
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Singh, A. D., Turell, M. E., & Topham, A. K. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.040 · Cited by 1,267
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Robertson, A. G., Shih, J., Yau, C., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 887
Self-citationHistone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Scheuermann, J. C., de Ayala Alonso, A. G., Oktaba, K., Ly-Hartig, N., McGinty, R. K., Fraterman, S., Wilm, M., Muir, T. W., & Müller, J. (2010) · Nature · doi:10.1038/nature08966 · Cited by 792
Onken, M. D., Worley, L. A., Ehlers, J. P., & Harbour, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1750 · Cited by 750
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., & Mizui, Y. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.16 · Cited by 657
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.18 · Cited by 650
Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes
Shields, C. L. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.208 · Cited by 626
Feng, X., Degese, M. S., Iglesias-Bartolome, R., Vaque, J. P., Molinolo, A. A., Rodrigues, M., Zaidi, M. R., Ksander, B. R., Merlino, G., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 563
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
O'Hayre, M., Vázquez-Prado, J., Kufareva, I., Stawiski, E. W., Handel, T. M., Seshagiri, S., & Gutkind, J. S. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3521 · Cited by 559
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
Harbour, J. W., Roberson, E. D. O., Anbunathan, H., Onken, M. D., Worley, L. A., & Bowcock, A. M. (2013) · Nature Genetics · doi:10.1038/ng.2523 · Cited by 516
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
Seiler, M., Yoshimi, A., Darman, R., Chan, B., Keaney, G., Thomas, M., Agrawal, A. A., Caleb, B., Csibi, A., Sean, E., et al. (2018) · Nature Medicine · doi:10.1038/nm.4493 · Cited by 507
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Hsu, T. Y.-T., Simon, L. M., Neill, N. J., Marcotte, R., Sayad, A., Bland, C. S., Echeverria, G. V., Sun, T., Kurley, S. J., Tyagi, S., et al. (2015) · Nature · doi:10.1038/nature14985 · Cited by 492
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Yu, F.-X., Luo, J., Mo, J.-S., Liu, G., Kim, Y. C., Meng, Z., Zhao, L., Peyman, G., Ouyang, H., Jiang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.017 · Cited by 463
Darman, R. B., Seiler, M., Agrawal, A. A., Lim, K. H., Peng, S., Aird, D., Bailey, S. L., Bhavsar, E. B., Chan, B., Colla, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.053 · Cited by 453
Seiler, M., Peng, S., Agrawal, A. A., Palacino, J., Teng, T., Zhu, P., Smith, P. G., Caesar-Johnson, S. J., Demchok, J. A., Felau, I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.088 · Cited by 444
Uveal melanoma: From diagnosis to treatment and the science in between
Chattopadhyay, C., Kim, D. W., Gombos, D. S., Oba, J., Qin, Y., Williams, M. D., Esmaeli, B., Grimm, E. A., Wargo, J. A., Woodman, S. E., et al. (2016) · Cancer · doi:10.1002/cncr.29727 · Cited by 443
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Furney, S. J., Pedersen, M., Gentien, D., Dumont, A. G., Rapinat, A., Desjardins, L., Turajlic, S., Piperno-Neumann, S., de la Grange, P., Roman-Roman, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0330 · Cited by 434
Carvajal, R. D., Sosman, J. A., Quevedo, J. F., Milhem, M. M., Joshua, A. M., Kudchadkar, R. R., Linette, G. P., Gajewski, T. F., Lutzky, J., Lawson, D. H., et al. (2014) · JAMA · doi:10.1001/jama.2014.6096 · Cited by 433
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Dey, A., Seshasayee, D., Noubade, R., French, D. M., Liu, J., Chaurushiya, M. S., Kirkpatrick, D. S., Pham, V. C., Lill, J. R., Bakalarski, C. E., et al. (2012) · Science · doi:10.1126/science.1221711 · Cited by 412
Eskelin, S. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00182-2 · Cited by 403
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Bononi, A., Giorgi, C., Patergnani, S., Larson, D., Verbruggen, K., Tanji, M., Pellegrini, L., Signorato, V., Olivetto, F., Pastorino, S., et al. (2017) · Nature · doi:10.1038/nature22798 · Cited by 401
Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E., Tirode, F., Constantinou, A., Piperno-Neumann, S., Roman-Roman, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10615 · Cited by 386
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
Yu, H., Pak, H., Hammond-Martel, I., Ghram, M., Rodrigue, A., Daou, S., Barbour, H., Corbeil, L., Hébert, J., Drobetsky, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309085110 · Cited by 383
Lee, S. C.-W., Dvinge, H., Kim, E., Cho, H., Micol, J.-B., Chung, Y. R., Durham, B. H., Yoshimi, A., Kim, Y. J., Thomas, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4097 · Cited by 347
Increased expression of histone deacetylase 2 is found in human gastric cancer
SONG, J., NOH, J. H., LEE, J. H., EUN, J. W., AHN, Y. M., KIM, S. Y., LEE, S. H., PARK, W. S., YOO, N. J., LEE, J. Y., et al. (2005) · APMIS · doi:10.1111/j.1600-0463.2005.apm_04.x · Cited by 346
Tschentscher, F., Hüsing, J., Hölter, T., Kruse, E., Dresen, I. G., Jöckel, K., Anastassiou, G., Schilling, H., Bornfeld, N., Horsthemke, B., et al. (2003) · PubMed · Cited by 323
Zhu, P., Zhou, W., Wang, J., Puc, J., Ohgi, K. A., Erdjument-Bromage, H., Tempst, P., Glass, C. K., & Rosenfeld, M. G. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.024 · Cited by 321
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
Moore, A. R., Ceraudo, E., Sher, J. J., Guan, Y., Shoushtari, A. N., Chang, M. T., Zhang, J. Q., Walczak, E. G., Kazmi, M. A., Taylor, B. S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3549 · Cited by 314
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., Hamaguchi, M., Hara, Y., Kobayashi, S., & Iwase, H. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6001-1 · Cited by 305
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
Johansson, P., Aoude, L. G., Wadt, K., Glasson, W. J., Warrier, S. K., Hewitt, A. W., Kiilgaard, J. F., Heegaard, S., Isaacs, T., Franchina, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6614 · Cited by 303
Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Landreville, S., Agapova, O. A., Matatall, K. A., Kneass, Z. T., Onken, M. D., Lee, R. S., Bowcock, A. M., & Harbour, J. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0946 · Cited by 289
Effectiveness of Treatments for Metastatic Uveal Melanoma
Augsburger, J. J., Corrêa, Z. M., & Shaikh, A. H. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.023 · Cited by 288
Rantala, E. S., Hernberg, M., & Kivelä, T. T. (2019) · Melanoma Research · doi:10.1097/cmr.0000000000000575 · Cited by 280
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1
Machida, Y. J., Machida, Y., Vashisht, A. A., Wohlschlegel, J. A., & Dutta, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.046755 · Cited by 274
Carvajal, R. D., Piperno-Neumann, S., Kapiteijn, E., Chapman, P. B., Frank, S., Joshua, A. M., Piulats, J. M., Wolter, P., Cocquyt, V., Chmielowski, B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1090 · Cited by 271
Yu, H., Mashtalir, N., Daou, S., Hammond-Martel, I., Ross, J., Sui, G., Hart, G. W., Rauscher, F. J., Drobetsky, E., Milot, E., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00396-10 · Cited by 270
Zimmer, L., Vaubel, J., Mohr, P., Hauschild, A., Utikal, J., Simon, J., Garbe, C., Herbst, R., Enk, A., Kämpgen, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118564 · Cited by 269
Uveal Melanomas with SF3B1 Mutations
Yavuzyigitoglu, S., Koopmans, A. E., Verdijk, R. M., Vaarwater, J., Eussen, B., van Bodegom, A., Paridaens, D., Kiliç, E., & de Klein, A. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.023 · Cited by 267
Self-citationEskens, F. A. L. M., Ramos, F. J., Burger, H., O'Brien, J. P., Piera, A., de Jonge, M. J. A., Mizui, Y., Wiemer, E. A. C., Carreras, M. J., Baselga, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0485 · Cited by 259
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Walpole, S., Pritchard, A. L., Cebulla, C. M., Pilarski, R., Stautberg, M., Davidorf, F. H., de la Fouchardière, A., Cabaret, O., Golmard, L., Stoppa-Lyonnet, D., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy171 · Cited by 253
Self-citationClinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma
Koopmans, A. E., Verdijk, R. M., Brouwer, R. W. W., van den Bosch, T. P. P., van den Berg, M. M. P., Vaarwater, J., Kockx, C. E. M., Paridaens, D., Naus, N. C., Nellist, M., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.43 · Cited by 224
Self-citationDetection of M2-Macrophages in Uveal Melanoma and Relation with Survival
Bronkhorst, I. H. G., Ly, L. V., Jordanova, E. S., Vrolijk, J., Versluis, M., Luyten, G. P. M., & Jager, M. J. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5979 · Cited by 219
Self-citationHong, D. S., Kurzrock, R., Naing, A., Wheler, J. J., Falchook, G. S., Schiffman, J. S., Faulkner, N., Pilat, M. J., O’Brien, J., & LoRusso, P. (2014) · Investigational New Drugs · doi:10.1007/s10637-013-0046-5 · Cited by 219
The genetic evolution of metastatic uveal melanoma
Shain, A. H., Bagger, M. M., Yu, R., Chang, D., Liu, S., Vemula, S., Weier, J. F., Wadt, K., Heegaard, S., Bastian, B. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0440-9 · Cited by 209
Bidard, F., Madic, J., Mariani, P., Piperno‐Neumann, S., Rampanou, A., Servois, V., Cassoux, N., Desjardins, L., Milder, M., Vaucher, I., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28436 · Cited by 201
Mashtalir, N., Daou, S., Barbour, H., Sen, N. N., Gagnon, J., Hammond-Martel, I., Dar, H. H., Therrien, M., & Affar, E. B. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.002 · Cited by 195
Punctuated evolution of canonical genomic aberrations in uveal melanoma
Field, M. G., Durante, M. A., Anbunathan, H., Cai, L. Z., Decatur, C. L., Bowcock, A. M., Kurtenbach, S., & Harbour, J. W. (2018) · Nature Communications · doi:10.1038/s41467-017-02428-w · Cited by 195
Kalirai, H., Dodson, A., Faqir, S., Damato, B. E., & Coupland, S. E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.417 · Cited by 192
Molecular architecture of polycomb repressive complexes
Chittock, E. C., Latwiel, S., Miller, T. C. R., & Müller, C. W. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160173 · Cited by 187
Biological validation that SF3b is a target of the antitumor macrolide pladienolide
Yokoi, A., Kotake, Y., Takahashi, K., Kadowaki, T., Matsumoto, Y., Minoshima, Y., Sugi, N. H., Sagane, K., Hamaguchi, M., Iwata, M., et al. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08387.x · Cited by 177
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma
Chen, X., Wu, Q., Depeille, P., Chen, P., Thornton, S., Kalirai, H., Coupland, S. E., Roose, J. P., & Bastian, B. C. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.002 · Cited by 171
Lack of BRAF mutations in uveal melanoma.
Rimoldi, D., Salvi, S., Líénard, D., Lejeune, F. J., Speiser, D. E., Zografos, L., & Cerottini, J. (2003) · PubMed · Cited by 169
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Fan, L., Lagisetti, C., Edwards, C. C., Webb, T. R., & Potter, P. M. (2011) · ACS Chemical Biology · doi:10.1021/cb100356k · Cited by 167
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
Matatall, K. A., Agapova, O. A., Onken, M. D., Worley, L. A., Bowcock, A. M., & Harbour, J. W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-371 · Cited by 159
Ewens, K. G., Kanetsky, P. A., Richards-Yutz, J., Purrazzella, J., Shields, C. L., Ganguly, T., & Ganguly, A. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-14550 · Cited by 158
ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma
Yoo, J. H., Shi, D., Grossmann, A. H., Sorensen, L. K., Tong, Z., Mleynek, T., Rogers, A., Zhu, W., Richards, J. R., Winter, J. M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.015 · Cited by 156
Grossmann, A. H., Yoo, J. H., Clancy, J. W., Sorensen, L. K., Sedgwick, A., Tong, Z., Ostanin, K., Rogers, A., Grossmann, K. F., Tripp, S. R., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2003398 · Cited by 152
Rodrigues, M. J., Mobuchon, L., Houy, A., Fiévet, A., Gardrat, S., Barnhill, R. L., Popova, T. G., Servois, V., Rampanou, A., Mouton, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04322-5 · Cited by 152
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
Damato, B. E., Dukes, J. D., Goodall, H., & Carvajal, R. D. (2019) · Cancers · doi:10.3390/cancers11070971 · Cited by 151
Monosomy of Chromosome 3 and an Inflammatory Phenotype Occur Together in Uveal Melanoma
Maat, W., Ly, L. V., Jordanova, E. S., de Wolff-Rouendaal, D., Schalij-Delfos, N. E., & Jager, M. J. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0786 · Cited by 147
Self-citationBronkhorst, I. H. G., Vu, T. H. K., Jordanova, E. S., Luyten, G. P. M., van der Burg, S. H., & Jager, M. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9280 · Cited by 143
Self-citationAn overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies
McClorey, G., & Wood, M. J. A. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.005 · Cited by 142
Field, M. G., Durante, M. A., Decatur, C. L., Tarlan, B., Oelschlager, K. M., Stone, J. F., Kuznetsoff, J. N., Bowcock, A. M., Kurtenbach, S., & Harbour, J. W. (2016) · Oncotarget · doi:10.18632/oncotarget.10962 · Cited by 134
Prognostic parameters in uveal melanoma and their association with BAP1 expression
van Essen, T. H., van Pelt, S. I., Versluis, M., Bronkhorst, I. H. G., van Duinen, S. G., Marinkovic, M., Kroes, W. G. M., Ruivenkamp, C. A. L., Shukla, S., de Klein, A., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305047 · Cited by 129
Self-citationDono, M., Angelini, G., Cecconi, M., Amaro, A. A., Esposito, A. I., Mirisola, V., Maric, I., Lanza, F. B., Nasciuti, F., Viaggi, S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.804 · Cited by 124
Organotropic metastasis: role of tumor exosomes
Liu, Y., & Cao, X. (2015) · Cell Research · doi:10.1038/cr.2015.153 · Cited by 122
Immune escape mechanisms of intraocular tumors
Niederkorn, J. Y. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.002 · Cited by 121
Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
Gezgin, G., Doğrusöz, M., van Essen, T. H., Kroes, W. G. M., Luyten, G. P. M., van der Velden, P. A., Walter, V., Verdijk, R. M., van Hall, T., van der Burg, S. H., et al. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1991-1 · Cited by 119
Self-citationGNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma
Moore, A. R., Ran, L., Guan, Y., Sher, J. J., Hitchman, T. D., Zhang, J. Q., Hwang, C., Walzak, E. G., Shoushtari, A. N., Monette, S., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.081 · Cited by 111
Highly Compacted Chromatin Formed In Vitro Reflects the Dynamics of Transcription Activation In Vivo
Li, G., Margueron, R., Hu, G., Stokes, D. L., Wang, Y.-H., & Reinberg, D. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.042 · Cited by 110
GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi
Vader, M., Madigan, M. C., Versluis, M., Suleiman, H. M., Gezgin, G., Gruis, N. A., Out‐Luiting, J. J., Bergman, W., Verdijk, R. M., Jager, M. J., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.259 · Cited by 110
Self-citationThe Cancer Genome Atlas Project: An Integrated Molecular View of Uveal Melanoma
Jager, M. J., Brouwer, N. J., & Esmaeli, B. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.03.011 · Cited by 110
Self-citationDigital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
Versluis, M., de Lange, M. J., van Pelt, S. I., Ruivenkamp, C. A. L., Kroes, W. G. M., Cao, J., Jager, M. J., Luyten, G. P. M., & van der Velden, P. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116371 · Cited by 108
Self-citationIn Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages
Ly, L. V., Baghat, A., Versluis, M., Jordanova, E. S., Luyten, G. P. M., van Rooijen, N., van Hall, T., van der Velden, P. A., & Jager, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903479 · Cited by 99
Self-citationJi, Z., Mohammed, H., Webber, A., Ridsdale, J., Han, N., Carroll, J. S., & Sharrocks, A. D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku274 · Cited by 95
Martín-Marcos, P., Zhou, F., Karunasiri, C., Zhang, F., Dong, J., Nanda, J. S., Kulkarni, S. D., Sen, N. D., Tamame, M., Zeschnigk, M., et al. (2017) · eLife · doi:10.7554/elife.31250 · Cited by 95
Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies
Komatsubara, K. M., & Carvajal, R. D. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0606-5 · Cited by 94
Zuidervaart, W., van der Velden, P. A., Hurks, H. M. H., van Nieuwpoort, F. A., Out‐Luiting, C., Singh, A. D., Frants, R. R., Jager, M. J., & Gruis, N. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601374 · Cited by 87
Self-citationMacrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
Jager, M. J., Ly, L. V., el Filali, M., & Madigan, M. C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.004 · Cited by 84
Self-citationPaolella, B. R., Gibson, W. J., Urbanski, L. M., Alberta, J. A., Zack, T. I., Bandopadhayay, P., Nichols, C. A., Agarwalla, P. K., Brown, M. S., Lamothe, R. C., et al. (2017) · eLife · doi:10.7554/elife.23268 · Cited by 84
Gene Expression Profiling in Uveal Melanoma: Two Regions on 3p Related to Prognosis
van Gils, W., Lodder, E. M., Mensink, H. W., Kılıç, E., Naus, N. C., Brüggenwirth, H. T., van IJcken, W. F. J., Paridaens, D. A., Luyten, G. P. M., & de Klein, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2033 · Cited by 83
Farquhar, N., Thornton, S., Coupland, S. E., Coulson, J. M., Sacco, J. J., Krishna, Y., Heimann, H., Taktak, A. F. G., Cebulla, C. M., Abdel‐Rahman, M. H., et al. (2017) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.86 · Cited by 78
The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors
Bommi, P. V., Dimri, M., Sahasrabuddhe, A. A., Khandekar, J. D., & Dimri, G. P. (2010) · Cell Cycle · doi:10.4161/cc.9.13.12147 · Cited by 76
Johansson, P. A., Stark, A. L., Palmer, J. M., Bigby, K., Brooks, K. M., Rolfe, O. J., Pritchard, A. L., Whitehead, K., Warrier, S., Glasson, W. J. H., et al. (2019) · Immunogenetics · doi:10.1007/s00251-019-01108-x · Cited by 75
Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations
Rodrigues, M. J., Mobuchon, L., Houy, A., Alsafadi, S., Baulande, S., Mariani, O., Marande, B., Raïs, K. A., van der Kooij, M. K., Kapiteijn, E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1215 · Cited by 65
In-depth proteomic profiling of the uveal melanoma secretome
Angi, M., Kalirai, H., Prendergast, S., Simpson, D. M., Hammond, D. E., Madigan, M. C., Beynon, R. J., & Coupland, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.10418 · Cited by 64
Shoushtari, A. N., Kudchadkar, R. R., Panageas, K. S., Murthy, R. K., Jung, M., Shah, R., O'Donnell, B., Khawaja, T. T., Shames, Y., Prempeh-Keteku, N. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.9511 · Cited by 58
Stålhammar, G., Seregard, S., & Grossniklaus, H. E. (2019) · Cancer Medicine · doi:10.1002/cam4.2167 · Cited by 58
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
Beasley, A. B., Isaacs, T., Khattak, M. A., Freeman, J. B., Allcock, R. J. N., Chen, F. K., Pereira, M. R., Yau, K. S., Bentel, J., Vermeulen, T. L., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00279 · Cited by 57
Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
Bol, K. F., van den Bosch, T., Schreibelt, G., Mensink, H. W., KEUNEN, J. E. E., Kılıç, E., Japing, W. J., Geul, K. W., Westdorp, H., Boudewijns, S., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.06.027 · Cited by 56
Metz, C. H. D., Scheulen, M. E., Bornfeld, N., Lohmann, D. R., & Zeschnigk, M. (2013) · Cancer Medicine · doi:10.1002/cam4.61 · Cited by 54
Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
van der Kooij, M. K., Joosse, A., Speetjens, F. M., Hospers, G. A. P., Bisschop, K., de Groot, J. W. B., Koornstra, R. H. T., Blank, C. U., & Kapiteijn, E. (2016) · Acta Oncologica · doi:10.1080/0284186x.2016.1260773 · Cited by 52
Kirchberger, M. C., Moreira, A., Erdmann, M., Schuler, G., & Heinzerling, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25627 · Cited by 49
Histone modifications: from genome-wide maps to functional insights.
van Leeuwen, F., & van Steensel, B. (2005) · Genome biology · doi:10.1186/gb-2005-6-6-113 · Cited by 47
Mouti, M. A., Dee, C., Coupland, S. E., & Hurlstone, A. F. L. (2016) · Oncotarget · doi:10.18632/oncotarget.9207 · Cited by 40
Immune Checkpoint Inhibitors in Uveal and Conjunctival Melanoma
Wierenga, A. P. A., Cao, J., Luyten, G. P. M., & Jager, M. J. (2019) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000263 · Cited by 40
Self-citationUveal melanoma driver mutations in GNAQ /11 yield numerous changes in melanocyte biology
Perez, D. E., Henle, A. M., Amsterdam, A., Hagen, H. R., & Lees, J. A. (2018) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12700 · Cited by 38
Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
Brouwer, N. J., Gezgin, G., Wierenga, A. P. A., Bronkhorst, I. H. G., Marinkovic, M., Luyten, G. P. M., Versluis, M., Kroes, W. G. M., van der Velden, P. A., Verdijk, R. M., et al. (2019) · Cancers · doi:10.3390/cancers11070979 · Cited by 35
Self-citationPeng, H., Prokop, J. W., Karar, J., Park, K., Cao, L. H., Harbour, J. W., Bowcock, A. M., Malkowicz, S. B., Cheung, M., Testa, J. R., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2876 · Cited by 31
Carvajal, R. D., Wong, M. K. K., Thompson, J. A., Gordon, M. S., Lewis, K. D., Pavlick, A. C., Wolchok, J. D., Rojas, P. B., Schwartz, J. D., & Bedikian, A. Y. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.03.289 · Cited by 25
Zoroquiaín, P., Espósito, E., Logan, P. T., Aldrees, S. S., Dias, A. B. T., Mansure, J. J., Santapau, D., García-Álvarez, C., Saornil, M. A., Neto, R. B., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0043-5 · Cited by 25
SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?
van Poppelen, N. M., Drabarek, W., Smit, K. N., Vaarwater, J., Brands, T., Paridaens, D. A., Kılıç, E., & de Klein, A. (2019) · Cancers · doi:10.3390/cancers11081200 · Cited by 25
Self-citationYAP as oncotarget in uveal melanoma
Yu, F., Zhang, K., & Guan, K. (2014) · Oncoscience · doi:10.18632/oncoscience.57 · Cited by 14
Cited by
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Yao, T., Zhang, Z., Li, Q., Huang, R., Hong, Y., Li, C., Zhang, F., Huang, Y., Fang, Y., Cao, Q., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0083 · Cited by 22
Metadata
- Authors
- Smit, K. N., Jager, M. J., de Klein, A., & Kiliҫ, E.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 75
- Pages
- 100800
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2976161620
- Cited by
- 264
- References
- 120
- FWCI
- 21.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.